ABN AMRO today announces that the Supervisory Board will nominate Frederieke Leeflang for appointment to the Supervisory Board of ABN AMRO Group N.V. and ABN AMRO Bank N.V. for a period of four years. The General Meeting of Shareholders will decide on her nomination on 18 May 2016. The nomination of Ms Leeflang has been approved by the supervisory authorities. The proposed appointment of Ms Leeflang will fill the vacancy created by Mr Wakkie’s resignation.
Rik van Slingelandt, Chairman of the Supervisory Board: ‘We are very pleased to nominate Frederieke Leeflang for appointment to the Supervisory Board. Her extensive legal expertise and experience will be highly valuable to the Supervisory Board in its supervision of ABN AMRO’s activities.’
Frederieke Leeflang has a degree in Law from the University of Groningen. She began her career in 1994 at the law offices of Boekel de Nerée (now Boekel) in Amsterdam. Having held various positions at the firm, she was Chair of the Board of Directors from 2011 to mid-2015. She has now returned to competition and supervisory law. Ms Leeflang also has relevant experience in the field of supervision, as a member of the Advisory Council for the Centrum Indicatiestelling Zorg (Care Assessment Centre), member of the Supervisory Board of KWF Kankerbestrijding (Dutch Cancer Society) and member of the Supervisory Board of Onderwijsstichting Zelfstandige Gymnasia. She is also a teacher and mentor for, among other organisations, the Women Leadership Programme and the Netherlands Bar Association.
ABN AMRO announced on 13 January 2016 that Arjen Dorland and Tjalling Tiemstra had been nominated for appointment to the bank’s Supervisory Board.